Travere Therapeutics's total assets for Q3 2025 were $538.58M, a decrease of -3.01% from the previous quarter. TVTX total liabilities were $465.02M for the fiscal quarter, a -11.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.